Haematology and Oncology Archives - Page 12 of 20

Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature

Luis Miguel Juárez-Salcedo MD, Diego Conde-Royo MD, Keina Quiroz-Cervantes MD, Samir Dalia MD

Article Type

Review

Published

06 May 2020

This article discusses the role of mAbs in follicular lymphoma and marginal zone lymphoma along with reviewing the current data about the use of biosimilar mAbs in these diseases.

Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management

Antonio Ruggiero MD, Palma Maurizi MD, Silvia Triarico MD, Michele Antonio Capozza MD, Stefano Mastrangelo MD, Giorgio Attinà MD

Article Type

Case Report

Published

26 Mar 2020

This paper describes two case studies of infants with multifocal infantile haemangiomatosis and hepatic involvement. A review of current therapeutic approaches is also presented.

Tumor lysis syndrome in childhood malignancies

Wing Lum Cheung MBBS, MRCPCH, Kam Lun Hon MBBS, MD (CUHK), FAAP, FCCM, Cheuk Man Fung MBChB, MRCPCH, Alexander KC Leung MBBS, FRCPC, FRCP (UK & Irel), FRCPCH, FAAP

Article Type

Review

Published

25 Feb 2020

This review provides an update on the current understanding, evaluation, and management of tumor lysis syndrome in childhood malignancies.

Combination checkpoint inhibitors for treatment of non-small-cell lung cancer: an update on dual anti-CTLA-4 and anti-PD-1/PD-L1 therapies

Sonam Puri MD, Michael Shafique MD

Article Type

Review

Published

13 Jan 2020

This review discusses the rationale, outcomes, and challenges of combination immune checkpoint blockade in non-small-cell lung cancer (NSCLC).

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

Donata Galbiati MD, Stefano Cavalieri MD, Salvatore Alfieri MD, Carlo Resteghini MD, Cristiana Bergamini MD, Ester Orlandi MD, Francesca Platini MD, Laura Locati MD, Luca Giacomelli PhD, Lisa Licitra MD, Paolo Bossi MD

Article Type

Original Research

Published

19 Dec 2019

This retrospective study aimed to review outcomes in patients with non-curable cutaneous squamous cell cancers treated with platinum-based chemotherapy and cetuximab.